Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AVANIR PHARMACEUTICALS | 15,392,318 | reported | 13 Jul 2010 | tx 1−165,000 |
| COMBINATORX, INC | 11,872,768 | reported | 26 Oct 2011 | tx 5−8,604,853 |
| ACHILLION PHARMACEUTICALS INC | 11,651,281 | reported | 31 May 2012 | tx 6+2,997,348−4,314,304 |
| Somaxon Pharmaceuticals, Inc. | 3,783,185 | reported | 06 Jun 2012 | tx 2−37,955 |
| RIGEL PHARMACEUTICALS INC | 3,333,586 | reported | 28 Jun 2004 | tx 22+11,569−2,506,681 |
| EnteroMedics Inc | 1,669,753 | reported | 14 Dec 2010 | tx 2+704,607−704,607 |
| ARYx Therapeutics, Inc. | 500,000 | reported | 30 Sept 2010 | tx 8+4,076,862−3,276,862 |
| KALOBIOS PHARMACEUTICALS INC | 15,000 | reported | 01 May 2013 | tx 7+2,647,928−2,563,040 |
| TERCICA INC | 11,250 | reported | 24 May 2007 | tx 7+7,079,997−6,387,497 |
| Altimmune, Inc. | 0 | reported | 28 Jul 2009 | tx 3−729,108 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jan 2023 | TENDER | Imago BioSciences, Inc. | 26,095 | 36.00 USD | |
| 11 Jan 2023 | OTHER | Imago BioSciences, Inc. | 11,904 | — | deriv |
| 01 Jun 2022 | GRANT_AWARD | Imago BioSciences, Inc. | 11,904 | 0.00 USD | deriv |
| 07 Apr 2020 | OTHER | Forty Seven, Inc. | 20,645 | — | deriv |
| 07 Apr 2020 | OTHER | Forty Seven, Inc. | 10,322 | — | deriv |
| 12 Jun 2019 | GRANT_AWARD | Forty Seven, Inc. | 10,322 | 0.00 USD | deriv |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 1,922,682 | — | |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 755,780 | — | |
| 02 Jul 2018 | PURCHASE | Forty Seven, Inc. | 200,000 | 16.00 USD | first after silence |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 938,489 | — | |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 1,922,682 | — | deriv |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 755,780 | — | deriv |
| 02 Jul 2018 | CONVERSION | Forty Seven, Inc. | 938,489 | — | deriv |
| 06 Jun 2014 | CONVERSION | MPM ACQUISITION CORP | 1,294,134 | — | |
| 06 Jun 2014 | CONVERSION | MPM ACQUISITION CORP | 1,045,351 | — | |
| 06 Jun 2014 | OTHER | MPM ACQUISITION CORP | 694,449 | — | |
| 06 Jun 2014 | CONVERSION | MPM ACQUISITION CORP | 399,891 | — | |
| 06 Jun 2014 | CONVERSION | MPM ACQUISITION CORP | 255,881 | — | |
| 06 Jun 2014 | CONVERSION | MPM ACQUISITION CORP | 217,873 | 0.00 USD | deriv |
| 06 Jun 2014 | CONVERSION | MPM ACQUISITION CORP | 53,331 | 0.00 USD | deriv |
| 06 Jun 2014 | CONVERSION | MPM ACQUISITION CORP | 91,175 | 0.00 USD | deriv |
| 06 Jun 2014 | CONVERSION | MPM ACQUISITION CORP | 269,724 | 0.00 USD | deriv |
| 01 May 2013 | GRANT_AWARD | KALOBIOS PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 05 Feb 2013 | CONVERSION | KALOBIOS PHARMACEUTICALS INC | 369,522 | — | |
| 05 Feb 2013 | CONVERSION | KALOBIOS PHARMACEUTICALS INC | 1,949,879 | — |
3 purchases reported after at least 12 months of silence — most recent on 02 Jul 2018.